5566.5000 73.50 (1.34%)
NSE Oct 15, 2025 15:31 PM
Volume: 171.8K
 

5566.50
1.34%
ICICI Securities Limited
Alkem Laboratories’ CEO, Dr. Vikas Gupta, is targeting double-digit revenue growth in the medium term, driven by strong hold in India (68% of sales), other international markets and new ventures.
Number of FII/FPI investors increased from 551 to 589 in Sep 2025 qtr.
More from Alkem Laboratories Ltd.
Recommended